How to Buy Kezar Life Sciences Stock
Kezar Life Sciences Inc
Kezar Life Sciences, Inc. , a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States.
Kezar Life Sciences stock last closed at $4.15, down 0.24% from the previous day, and has decreased 49.51% in one year. It has overperformed other stocks in the Biotechnology industry by 0.28 percentage points. Kezar Life Sciences stock is currently +14.64% from its 52-week low of $3.62, and -54.79% from its 52-week high of $9.18.
At the moment, there are 7.31M KZR shares outstanding. The market cap of KZR is $30.32M. In the past 24 hours, 23,136 KZR shares were traded.
How to Buy Kezar Life Sciences Stock
Wondering how to invest in Kezar Life Sciences stock? Here's how.
- Decide where to buy Kezar Life Sciences stock: You need to decide on a stock brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you decide where to buy Kezar Life Sciences stock.
- Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Put funds into your brokerage account: Pick your method of payment and add your details.
- Research Kezar Life Sciences stock: The Kezar Life Sciences ticker symbol is KZR. Is Kezar Life Sciences stock a good investment? Should you buy shares of KZR? How do KZR's underlying business fundamentals look? Do top analysts think Kezar Life Sciences is a good buy? Why has KZR's stock price moved recently? (Hint: Our stock market analysis website can help you understand if KZR is a good stock to buy).
- Execute your KZR purchase: Decide if you will purchase KZR shares at the current market price or use a limit order to purchase KZR stock at a specific price.
- Keep tabs on your KZR investment: Create a watchlist to get live updates on your investment in Kezar Life Sciences stock.
Step 1: Decide where to buy Kezar Life Sciences stock
You need an online brokerage account to access the NASDAQ market and buy KZR shares.
Our preferred brokerage: eToro
Based on our experience, eToro is the best brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to global markets: From Tech to Healthcare, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro has a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've selected the right brokerage, you need to fill out some personal details so you can buy KZR stock today.
How to Open a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to start a new trading account.
- Submit your information by hitting the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you have finished signing up on one of the best stock trading apps, you can securely and quickly fund your account:
Check out the walkthrough below for more details depositing funds into your brokerage account.
Step 4: Research Kezar Life Sciences stock
After you have decided on the best place to buy Kezar Life Sciences stock, it's absolutely critical to research their stock prior to buying, so you can wrap your head around the risk as well as the opportunity.
Overview of key KZR info
Fundamentals of Kezar Life Sciences
WallStreetZen was built to help everyday investors do more in-depth fundamental analysis.
You can view all of the due diligence checks on KZR's stock page.
How is KZR stock valued?
Investors use many financial metrics, analyses, models, and charts to gauge KZR's intrinsic value.
Using relative valuations ratios:
- KZR may be undervalued based on its P/B ratio of 0.26x, relative to Biotechnology industry P/B ratio of 4.04x
You can do more valuation analysis on KZR's stock here.
A quick look at KZR Financials
Passed Financial Due Diligence Checks:
- There are more short-term assets than long-term liabilities on the KZR balance sheet.
- KZR has a low debt to equity ratio of 0.24.
- KZR has cash burn of 74241000. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the KZR balance sheet.
Failed Financial Due Diligence Checks:
- Total KZR debt is higher than 5 years ago, relative to shareholder equity.
- KZR has $132.25M in cash and short term investments. This is not enough to cover its annual cash burn of $74.24M.
Do analysts think it's a good time to buy Kezar Life Sciences stock
Out of 1 Wall Street analysts who track KZR, the consensus analyst rating on Kezar Life Sciences is a Hold
It's important to keep in mind that analyst forecasts are not recommendations, nor are they investment advice.
You can dig deeper into what analysts are forecasting on the Kezar Life Sciences stock forecast page.
KZR Trading Indicators
KZR Performance Numbers
Last year, KZR revenue was $0.00. Over the last 1 years, KZR's revenue has grown by -100% per year. This was slower than the Biotechnology industry average of 44.31%.
Learn more about KZR's earnings and revenue performance here.
Are KZR executives and large shareholders buying or selling the stock?
In the past 12 months, insiders at KZR have sold more shares than they have bought.
Mark C. Schiller, Chief Legal Officer of KZR, was the latest KZR insider to sell. They sold $3,879.04 worth of KZR stock on Jul 2, 2024.
Get more info about who owns KZR shares here.
Can I rely on KZR as an income stream?
No, Kezar Life Sciences doesn't provide an income stream by paying out dividends.
KZR Social Trading Data
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Execute your KZR purchase
There are two primary options:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are generally the easiest way to buy. - Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
If you want to ensure you're buying or selling at a specific price limit, use a limit order.
Press the Open button and eToro will place the order.
If you need more info about buying stocks on eToro, watch the helpful video below:
Step 6: Keep tabs on your KZR investment
Now that you own some KZR shares, you'll want to keep up with your investment.
Put KZR on a watchlist to track the most important metrics related to your KZR stock.
KZR Feed
How to Buy Stock in Kezar Life Sciences
To reiterate, here are the 6 steps to buy Kezar Life Sciences stock:
- Decide where to buy Kezar Life Sciences stock
- Open a brokerage account
- Put funds into your brokerage account
- Research Kezar Life Sciences stock
- Execute your KZR purchase
- Keep tabs on your KZR investment
If you need a online brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to get the latest news on your investment in Kezar Life Sciences, get started below.
Other Content You May Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.